{"id":"W4410900800","doi":"10.5489/cuaj.9073","title":"Adjuvant pembrolizumab following kidney cancer surgery","year":2025,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; Dalhousie University; McGill University; Kidney Foundation of Canada; McMaster University","funders":"","keywords":"Pembrolizumab; Medicine; Kidney cancer; Adjuvant; Cancer; Surgery; Oncology; General surgery; Internal medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584059,0.0003589028,0.0007890836,0.0005855075,0.003050762,0.001654527,0.0007896985,0.01353018,0.004952994],"category_scores_gemma":[0.007511118,0.0003064212,0.0009698974,0.0005897144,0.001093127,0.000975305,0.0005613787,0.009378213,0.001704796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005275996,"about_ca_system_score_gemma":0.004658432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01087198,"about_ca_topic_score_gemma":0.03524031,"domain_scores_codex":[0.9993606,0.0001224003,0.00009163513,0.00005691686,0.0001553287,0.0002131463],"domain_scores_gemma":[0.9977599,0.000889554,0.000226709,0.00005767347,0.0002151302,0.0008509191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006582633,0.000291417,0.01332085,0.0003567645,0.0001244522,0.2927564,0.0003499543,0.0007253469,0.001728398,0.004514151,0.6206568,0.0645172],"study_design_scores_gemma":[0.0007800685,0.0008766138,0.0264346,0.001150932,0.0003104573,0.3100888,0.001250324,0.003715147,0.001979978,0.01428949,0.6389712,0.0001523791],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.01623306,0.009027297,0.0004460602,0.9252676,0.02227559,0.00006348145,0.0001542937,0.0000602692,0.02647234],"genre_scores_gemma":[0.2169903,0.01086703,0.001037297,0.6389067,0.100887,0.0000706085,0.0002624329,0.0000519048,0.0309268],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01353018,"threshold_uncertainty_score":0.03828019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01625789827309259,"score_gpt":0.2516237017278577,"score_spread":0.2353658034547651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}